ALS News: Breakthrough Drug Shows Promising Results in Clinical Trials Introduction Recent ALS news reveals a groundbreaking personalized drug therapy that has demonstrated remarkable efficacy in slowing ALS progression. In April 2024, a patient received the first-ever antisense oligonucleotide (ASO) treatment targeting CHCHD10 mutations in
Tag: SOD1
